Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-12 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-12 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-12 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-12 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-12 |
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-12 |